Investigator
Jing Hong Wang
UNIVERSITY OF PITTSBURGH AT PITTSBURGH · funded by NIDCR, NCI
- Companies
- 1
- Grants
- 3
- Non-dilutive funding
- $3.2M
- First award
- Apr 1, 2024
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Sep 19, 2025.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- Zhejiang Yangli Pharmaceutical Technology Co., Ltd.95momentum
OncologyPhase II
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R01
Analysis of high dimensional genomic dataset to reveal mechanistic insights on divergent outcomes of head and neck cancer using system biology modeling coupled with experimental validation
$1.9MSep 19, 2025NIDCRUNIVERSITY OF PITTSBURGH AT PITTSBURGHNIH RePORTER · 11144132 (opens the source filing in a new tab)
- R01
Mechanistic connection between HPV-specific TCRs and therapeutic responses to ICI in HPV+ HNSCC
$655kApr 1, 2024NCIUNIVERSITY OF PITTSBURGH AT PITTSBURGHNIH RePORTER · 11056170 (opens the source filing in a new tab)
- R01
Mechanistic connection between HPV-specific TCRs and therapeutic responses to ICI in HPV+ HNSCC
$655kApr 1, 2024NCIUNIVERSITY OF PITTSBURGH AT PITTSBURGHNIH RePORTER · 11306668 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources